
A five-year, £5 million initiative has just been launched to investigate the feasibility of using new blood tests in the diagnosis of Alzheimer’s disease. Alzheimer’s Research UK and the Alzheimer’s Society are working with the National Institute for Health and Care Research to use these blood tests in the NHS.
This funding, hot on the heels of recent drug trials for Alzheimer’s disease, continues a wave of breathless excitement in a field that has traditionally found good news stories hard to come by.